The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Male Hypogonadism-Global Market Insights and Sales Trends 2025

Male Hypogonadism-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1828102

No of Pages : 104

Ask Your Query

Synopsis

Male hypogonadism is a condition in which the body doesn't produce enough of the hormone that plays a key role in masculine growth and development during puberty (testosterone) or enough sperm or both. You can be born with male hypogonadism, or it can develop later in life, often from injury or infection.

The global Male Hypogonadism market size is expected to reach US$ 3721.7 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Male Hypogonadism in various end use industries. The expanding demands from the Kallmann Syndrome, Klinefelters Syndrome, Pituitary Disorders and Others, are propelling Male Hypogonadism market. Testosterone Replacement Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Gonadotropin-Releasing Hormones Therapy segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Male Hypogonadism market, driven by demand from China, the second largest economy with some signs of stabilising, the Male Hypogonadism market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Male Hypogonadism, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Male Hypogonadism market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Male Hypogonadism market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Male Hypogonadism sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Male Hypogonadism covered in this report include Astrazeneca Plc., Merck & Co. Inc., Laboratories Genevrier, Allergan Plc., Endo International Plc., Ferring, AbbVie Inc., Eli Lilly and Company Ltd. and Finox Biotech, etc.

The global Male Hypogonadism market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Astrazeneca Plc.
  • Merck & Co. Inc.
  • Laboratories Genevrier
  • Allergan Plc.
  • Endo International Plc.
  • Ferring
  • AbbVie Inc.
  • Eli Lilly and Company Ltd.
  • Finox Biotech
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • IBSA Institut Biochimque

Global Male Hypogonadism market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Male Hypogonadism market, Segment by Type:

  • Testosterone Replacement Therapy
  • Gonadotropin-Releasing Hormones Therapy

Global Male Hypogonadism market, by Application

  • Kallmann Syndrome
  • Klinefelters Syndrome
  • Pituitary Disorders
  • Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Male Hypogonadism companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Male Hypogonadism
1.1 Male Hypogonadism Market Overview
1.1.1 Male Hypogonadism Product Scope
1.1.2 Male Hypogonadism Market Status and Outlook
1.2 Global Male Hypogonadism Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Male Hypogonadism Market Size by Region (2018-2029)
1.4 Global Male Hypogonadism Historic Market Size by Region (2018-2023)
1.5 Global Male Hypogonadism Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Male Hypogonadism Market Size (2018-2029)
1.6.1 North America Male Hypogonadism Market Size (2018-2029)
1.6.2 Europe Male Hypogonadism Market Size (2018-2029)
1.6.3 Asia-Pacific Male Hypogonadism Market Size (2018-2029)
1.6.4 Latin America Male Hypogonadism Market Size (2018-2029)
1.6.5 Middle East & Africa Male Hypogonadism Market Size (2018-2029)
2 Male Hypogonadism Market by Type
2.1 Introduction
2.1.1 Testosterone Replacement Therapy
2.1.2 Gonadotropin-Releasing Hormones Therapy
2.2 Global Male Hypogonadism Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Male Hypogonadism Historic Market Size by Type (2018-2023)
2.2.2 Global Male Hypogonadism Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Male Hypogonadism Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Male Hypogonadism Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Male Hypogonadism Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Male Hypogonadism Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Male Hypogonadism Revenue Breakdown by Type (2018-2029)
3 Male Hypogonadism Market Overview by Application
3.1 Introduction
3.1.1 Kallmann Syndrome
3.1.2 Klinefelters Syndrome
3.1.3 Pituitary Disorders
3.1.4 Others
3.2 Global Male Hypogonadism Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Male Hypogonadism Historic Market Size by Application (2018-2023)
3.2.2 Global Male Hypogonadism Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Male Hypogonadism Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Male Hypogonadism Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Male Hypogonadism Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Male Hypogonadism Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Male Hypogonadism Revenue Breakdown by Application (2018-2029)
4 Male Hypogonadism Competition Analysis by Players
4.1 Global Male Hypogonadism Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Male Hypogonadism as of 2022)
4.3 Date of Key Players Enter into Male Hypogonadism Market
4.4 Global Top Players Male Hypogonadism Headquarters and Area Served
4.5 Key Players Male Hypogonadism Product Solution and Service
4.6 Competitive Status
4.6.1 Male Hypogonadism Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Astrazeneca Plc.
5.1.1 Astrazeneca Plc. Profile
5.1.2 Astrazeneca Plc. Main Business
5.1.3 Astrazeneca Plc. Male Hypogonadism Products, Services and Solutions
5.1.4 Astrazeneca Plc. Male Hypogonadism Revenue (US$ Million) & (2018-2023)
5.1.5 Astrazeneca Plc. Recent Developments
5.2 Merck & Co. Inc.
5.2.1 Merck & Co. Inc. Profile
5.2.2 Merck & Co. Inc. Main Business
5.2.3 Merck & Co. Inc. Male Hypogonadism Products, Services and Solutions
5.2.4 Merck & Co. Inc. Male Hypogonadism Revenue (US$ Million) & (2018-2023)
5.2.5 Merck & Co. Inc. Recent Developments
5.3 Laboratories Genevrier
5.3.1 Laboratories Genevrier Profile
5.3.2 Laboratories Genevrier Main Business
5.3.3 Laboratories Genevrier Male Hypogonadism Products, Services and Solutions
5.3.4 Laboratories Genevrier Male Hypogonadism Revenue (US$ Million) & (2018-2023)
5.3.5 Allergan Plc. Recent Developments
5.4 Allergan Plc.
5.4.1 Allergan Plc. Profile
5.4.2 Allergan Plc. Main Business
5.4.3 Allergan Plc. Male Hypogonadism Products, Services and Solutions
5.4.4 Allergan Plc. Male Hypogonadism Revenue (US$ Million) & (2018-2023)
5.4.5 Allergan Plc. Recent Developments
5.5 Endo International Plc.
5.5.1 Endo International Plc. Profile
5.5.2 Endo International Plc. Main Business
5.5.3 Endo International Plc. Male Hypogonadism Products, Services and Solutions
5.5.4 Endo International Plc. Male Hypogonadism Revenue (US$ Million) & (2018-2023)
5.5.5 Endo International Plc. Recent Developments
5.6 Ferring
5.6.1 Ferring Profile
5.6.2 Ferring Main Business
5.6.3 Ferring Male Hypogonadism Products, Services and Solutions
5.6.4 Ferring Male Hypogonadism Revenue (US$ Million) & (2018-2023)
5.6.5 Ferring Recent Developments
5.7 AbbVie Inc.
5.7.1 AbbVie Inc. Profile
5.7.2 AbbVie Inc. Main Business
5.7.3 AbbVie Inc. Male Hypogonadism Products, Services and Solutions
5.7.4 AbbVie Inc. Male Hypogonadism Revenue (US$ Million) & (2018-2023)
5.7.5 AbbVie Inc. Recent Developments
5.8 Eli Lilly and Company Ltd.
5.8.1 Eli Lilly and Company Ltd. Profile
5.8.2 Eli Lilly and Company Ltd. Main Business
5.8.3 Eli Lilly and Company Ltd. Male Hypogonadism Products, Services and Solutions
5.8.4 Eli Lilly and Company Ltd. Male Hypogonadism Revenue (US$ Million) & (2018-2023)
5.8.5 Eli Lilly and Company Ltd. Recent Developments
5.9 Finox Biotech
5.9.1 Finox Biotech Profile
5.9.2 Finox Biotech Main Business
5.9.3 Finox Biotech Male Hypogonadism Products, Services and Solutions
5.9.4 Finox Biotech Male Hypogonadism Revenue (US$ Million) & (2018-2023)
5.9.5 Finox Biotech Recent Developments
5.10 Teva Pharmaceutical Industries Ltd.
5.10.1 Teva Pharmaceutical Industries Ltd. Profile
5.10.2 Teva Pharmaceutical Industries Ltd. Main Business
5.10.3 Teva Pharmaceutical Industries Ltd. Male Hypogonadism Products, Services and Solutions
5.10.4 Teva Pharmaceutical Industries Ltd. Male Hypogonadism Revenue (US$ Million) & (2018-2023)
5.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments
5.11 Bayer AG
5.11.1 Bayer AG Profile
5.11.2 Bayer AG Main Business
5.11.3 Bayer AG Male Hypogonadism Products, Services and Solutions
5.11.4 Bayer AG Male Hypogonadism Revenue (US$ Million) & (2018-2023)
5.11.5 Bayer AG Recent Developments
5.12 IBSA Institut Biochimque
5.12.1 IBSA Institut Biochimque Profile
5.12.2 IBSA Institut Biochimque Main Business
5.12.3 IBSA Institut Biochimque Male Hypogonadism Products, Services and Solutions
5.12.4 IBSA Institut Biochimque Male Hypogonadism Revenue (US$ Million) & (2018-2023)
5.12.5 IBSA Institut Biochimque Recent Developments
6 North America
6.1 North America Male Hypogonadism Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Male Hypogonadism Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Male Hypogonadism Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Male Hypogonadism Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Male Hypogonadism Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Male Hypogonadism Market Dynamics
11.1 Male Hypogonadism Industry Trends
11.2 Male Hypogonadism Market Drivers
11.3 Male Hypogonadism Market Challenges
11.4 Male Hypogonadism Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock